Form D · Biotechnology
ProMed Investment Holdings, LLC
Chicago, IL · CIK 0001665044
Offering snapshot reported Jan 29, 2016 · SEC filing
- Reported sold
- $4.4M Offering amount: $4.4M
- Investors reported
- 44 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 31, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 29, 2016 | Initial | $4,400,000 | No comparison | 44 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-256311
Additional capital commitments in excess of the Total Offering Amount were accepted.
Source: Form D, filed Jan 29, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
The linked fund shows its most recently reported ADV details.
Matched by reported Form D file number
PROMED INVESTMENT HOLDINGS, LLC
Investment adviser: PROMUS ASSET MANAGEMENT, LLC
- Gross asset value
- $15.1M
- Beneficial owners
- 44
- ADV minimum commitment
- $20K
Reported in Form ADV on Jul 2, 2024. Fund assets and beneficial owners measure different things from Form D sales and investors.
Service providers
Provider details
- Annual audit
- Yes
- Prime brokers
- No
- Custodians
- Yes
- Administrator other than the adviser
- No
- External marketing
- No
PLANTE & MORAN, PLLC
PCAOB 166
HINSDALE BANK & TRUST COMPANY, N.A.
LEI 9LIMABRJ9VPV74PBJB17
Filing source
Form ADV 1887062 · Jul 2, 2024 · Schedule D 7.B.(1), fund 805-1277219649
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| N/A Promus Equity Partners, Llc | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:Chicago, IL, 60606